LIPID PEROXIDATION IN PATIENTS WITH COPD AND CHRONIC HEART FAILURE.

I. Klimanov (Moscow, Russian Federation), A. Khaletskaya (Nizhny Novgorod, Russian Federation), A. Kuznechov (Nizhny Novgorod, Russian Federation), K. Kontorschikova (Nizhny Novgorod, Russian Federation), N. Kubysheva (Kazan, Russian Federation), D. Leonova (Nizhny Novgorod, Russian Federation), A. Bobkova (Nizhny Novgorod, Russian Federation), S. Soodaeva (Moscow, Russian Federation)

Source: International Congress 2018 – Functional genomics and COPD: new challenges
Session: Functional genomics and COPD: new challenges
Session type: Thematic Poster
Number: 931
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Klimanov (Moscow, Russian Federation), A. Khaletskaya (Nizhny Novgorod, Russian Federation), A. Kuznechov (Nizhny Novgorod, Russian Federation), K. Kontorschikova (Nizhny Novgorod, Russian Federation), N. Kubysheva (Kazan, Russian Federation), D. Leonova (Nizhny Novgorod, Russian Federation), A. Bobkova (Nizhny Novgorod, Russian Federation), S. Soodaeva (Moscow, Russian Federation). LIPID PEROXIDATION IN PATIENTS WITH COPD AND CHRONIC HEART FAILURE.. 931

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
DIFFERENCES IN THE QUALITY OF LIFE BETWEEN PATIENTS WITH LEFT HEART FAILURE AND RIGHT HEART FAILURE SECONDARY TO COPD
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020

DIFFERENCES IN PSYCHOLOGICAL FACTORS BETWEEN PATIENTS WITH LEFT HEART FAILURE AND RIGHT HEART FAILURE ASSOCIATED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: Virtual Congress 2020 – Pulmonary embolism and beyond
Year: 2020

HEART VARIABILITY IN THE PRESENCE OF PSYCHOLOGICAL STRESS AND QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020

QUALITY OF LIFE OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THEIR CAREGIVERS
Source: Virtual Congress 2020 – Organising respiratory disease management in primary care
Year: 2020

SALBUTAMOL AND IPRATROPIUM BROMIDE ARE HIGH RISK FACTORS FOR ATRIAL ARRHYTHMIAS IN PATIENTS WITH COPD AND CVS DISEASES.
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019

IMMUNOLOGICAL EVENTS AND SURVIVAL IN LUNG CANCER PATIENTS WITH COPD
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020


PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: Virtual Congress 2020 – Prognosis and integrated management of COPD
Year: 2020


THE POTENTIAL IMPACT OF ANAEMIA OF CHRONIC DISEASE IN COPD.
Source: Eur Respir J 2006; 27: 1076
Year: 2006


USEFULNESS OF MIRNAS AS PREDICTORS OF LUNG CANCER IN PATIENTS WITH COPD. A PILOT SUTDY
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021



IMPACT OF TELEMONITORING ON PATIENTS WITH ADVANCED CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019


PULMONARY REHABILITATION EFFECT ON SYSTEMIC INFLAMMATION VALUES, APOB48, LIPIDEMIA AND CARDIOVASCULAR RISK IN PATIENTS WITH COPD
Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases
Year: 2019


PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH INTERSTITIAL PULMONARY DISEASE
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Year: 2020


SYSTEMIC EFFECT OF CONTINUOUS TREATMENT WITH AZITHROMYCYN IN PATIENTS WITH SEVERE COPD AND FREQUENT EXACERBATIONS
Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights
Year: 2019




UTILITY OF THE HIGH FLOW WITH NASAL CANNULA IN THE DECANULATION OF TRAQUEOTOMIZED PATIENTS DURING AN EPISODE OF ACUTE RESPIRATORY INSUFFICIENCY.
Source: International Congress 2018 – New tools for managing respiratory failure
Year: 2018

GLN27GLU POLYMORPHISM IN THE ß2-ADRENERGIC RECEPTOR GENE AND THE RISK OF ARTERIAL HYPERTENSION IN PATIENTS WITH BRONCHIAL ASTHMA
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018


IMPACT OF NON-INVASIVE VENTILATION IMMEDIATELY AFTER EXTUBATION ON CLINICAL AND FUNCTIONAL OUTCOMES IN PATIENTS SUBMITTED TO CORONARY ARTERY BYPASS GRAFTING: CLINICAL TRIAL
Source: Virtual Congress 2021 – An update on respiratory physiotherapy and respiratory muscle function and training
Year: 2021


A RESPIRATORY TELEREHABILITATION PROGRAM AS MAINTENANCE  IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation
Year: 2018



PULMONARY HYPERTENSION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ON ANTI-FIBROTIC TREATMENT WITH PIRFENIDONE OR NINTEDANIB: CLINICAL EVALUATION AND PROGNOSTIC IMPACT
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021

THE EFFECT OF TIOTROPIUM ON EXACERBATIONS AND AIRFLOW IN PATIENTS WITH COPD.
Source: Eur Respir J 2006; 27: 1076
Year: 2006


ORAL MORPHINE IS SAFE IN SYMPTOMATIC PATIENTS WITH FIBROTIC INTERSTITIAL LUNG DISEASES
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019